- Report
- May 2025
- 183 Pages
Global
From €3112EUR$3,545USD£2,670GBP
€3458EUR$3,939USD£2,967GBP
- Report
- May 2025
- 192 Pages
Global
From €3112EUR$3,545USD£2,670GBP
€3458EUR$3,939USD£2,967GBP
- Report
- May 2025
- 191 Pages
Global
From €3112EUR$3,545USD£2,670GBP
€3458EUR$3,939USD£2,967GBP
- Report
- May 2025
- 194 Pages
Global
From €3112EUR$3,545USD£2,670GBP
€3458EUR$3,939USD£2,967GBP
- Report
- May 2025
- 193 Pages
Global
From €3112EUR$3,545USD£2,670GBP
€3458EUR$3,939USD£2,967GBP
- Report
- April 2025
- 125 Pages
Global
From €5223EUR$5,950USD£4,482GBP
- Report
- April 2025
- 250 Pages
Global
From €3941EUR$4,490USD£3,382GBP
- Report
- April 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,382GBP
- Report
- February 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,382GBP
- Report
- July 2025
- 384 Pages
Global
From €5135EUR$5,850USD£4,407GBP
- Report
- July 2025
- 372 Pages
Global
From €5135EUR$5,850USD£4,407GBP
- Report
- July 2025
- 182 Pages
Global
From €5135EUR$5,850USD£4,407GBP
- Report
- July 2025
- 268 Pages
Global
From €4784EUR$5,450USD£4,105GBP
- Report
- July 2025
- 357 Pages
Global
From €5135EUR$5,850USD£4,407GBP
- Report
- March 2025
- 180 Pages
Global
From €3358EUR$3,825USD£2,881GBP
€3950EUR$4,500USD£3,390GBP
- Report
- September 2024
- 187 Pages
Global
From €3358EUR$3,825USD£2,881GBP
€3950EUR$4,500USD£3,390GBP
- Report
- August 2024
- 180 Pages
Global
From €3358EUR$3,825USD£2,881GBP
€3950EUR$4,500USD£3,390GBP
- Report
- May 2025
- 106 Pages
Global
From €4170EUR$4,750USD£3,578GBP
- Report
- June 2025
- 150 Pages
Global
From €3380EUR$3,850USD£2,900GBP
- Report
- March 2025
- 150 Pages
Global
From €2853EUR$3,250USD£2,448GBP
€4257EUR$4,850USD£3,653GBP

Hemovigilance is a term used to describe the monitoring and surveillance of blood products and transfusions. It is an important part of the blood banking industry, as it helps to ensure the safety of blood products and transfusions. Hemovigilance involves the collection and analysis of data related to the safety of blood products and transfusions, as well as the identification of any potential risks. This data is then used to inform the development of safety protocols and procedures, as well as to identify any potential areas of improvement.
Hemovigilance is also used to monitor the quality of blood products and transfusions, as well as to ensure that they meet the necessary standards. This helps to ensure that the blood products and transfusions are safe and effective for use.
Some companies in the Hemovigilance market include Bio-Rad Laboratories, Grifols, and Immucor. Show Less Read more